Enzo Biochem, Inc. Press Releases

ENZ 
$5.03
*  
0.05
1%
Get ENZ Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading ENZ now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing

Enzo Biochem Submits AmpiProbe Based Assay Targeted at Women’s Health for Approval to New York State Department of Health
3/10/2016 7:45:00 AM - Business Wire
▲16.71 % Price Change since this news event. The Volume Ratio is 1.87.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Enzo Biochem Reports Increased Fiscal Second Quarter Results
3/9/2016 4:05:00 PM - Business Wire
▲16.71 % Price Change since this news event. The Volume Ratio is 1.41.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Enzo Biochem Schedules Teleconference to Discuss Second Quarter 2016 Results Thursday, March 10, 2016 at 8:30 AM E.T.
3/2/2016 12:03:00 PM - Business Wire
▲20.62 % Price Change since this news event. The Volume Ratio is 1.6.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day